Cargando…

Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains

Late onset Alzheimer’s disease (LOAD) etiology is influenced by complex interactions between genetic and environmental risk factors. Large-scale genome wide association studies (GWAS) for LOAD have identified 10 novel risk genes: ABCA7, BIN1, CD2AP, CD33, CLU, CR1, EPHA1, MS4A6A, MS4A6E, and PICALM....

Descripción completa

Detalles Bibliográficos
Autores principales:	Karch, Celeste M., Jeng, Amanda T., Nowotny, Petra, Cady, Janet, Cruchaga, Carlos, Goate, Alison M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511432/ https://www.ncbi.nlm.nih.gov/pubmed/23226438 http://dx.doi.org/10.1371/journal.pone.0050976

Ejemplares similares

Alzheimer’s Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci
por: Karch, Celeste M., et al.
Publicado: (2016)

Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration
por: Honea, Robyn A., et al.
Publicado: (2013)

Discovery and validation of autosomal dominant Alzheimer’s disease mutations
por: Hsu, Simon, et al.
Publicado: (2018)

Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
por: Kauwe, John S. K., et al.
Publicado: (2011)

Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease
por: Fernández, Maria V., et al.
Publicado: (2018)

Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the London mutation in APP (V717I)
por: Hernández, Damián, et al.
Publicado: (2021)

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer’s disease brains
por: Novotny, Brenna C., et al.
Publicado: (2023)

The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-ε4 Carriers
por: Benitez, Bruno A., et al.
Publicado: (2013)

Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease
por: Fernández, Maria Victoria, et al.
Publicado: (2017)

Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort
por: Jin, Sheng Chih, et al.
Publicado: (2012)

Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression
por: Saito, Erin R., et al.
Publicado: (2021)

Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
por: Efthymiou, Anastasia G., et al.
Publicado: (2017)

Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations
por: Dube, Umber, et al.
Publicado: (2019)

Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer’s Disease
por: Sassi, Celeste, et al.
Publicado: (2016)

Identification of rare variants in Alzheimer’s disease
por: Lord, Jenny, et al.
Publicado: (2014)

SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease
por: Cruchaga, Carlos, et al.
Publicado: (2010)

Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2021)

Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network
por: Karch, Celeste M., et al.
Publicado: (2018)

Heterogeneous effects of genetic risk for Alzheimer’s disease on the phenome
por: Wu, Hei Man, et al.
Publicado: (2021)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
por: Ibanez, Laura, et al.
Publicado: (2021)

Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation
por: Kauwe, John S. K., et al.
Publicado: (2014)

The complex genetic architecture of Alzheimer's disease: novel insights and future directions
por: Andrews, Shea J., et al.
Publicado: (2023)

Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2022)

Locus specific endogenous retroviral expression associated with Alzheimer’s disease
por: Dawson, Tyson, et al.
Publicado: (2023)

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2018)

Discovery and validation of dominantly inherited Alzheimer’s disease mutations in populations from Latin America
por: Takada, Leonel Tadao, et al.
Publicado: (2022)

Epistatic Features and Machine Learning Improve Alzheimer’s Risk Prediction Over Polygenic Risk Scores
por: Hermes, Stephen, et al.
Publicado: (2023)

Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease
por: Baker, Emily, et al.
Publicado: (2019)

Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience
por: Ridge, Perry G., et al.
Publicado: (2017)

Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structure
por: Li, Zeran, et al.
Publicado: (2018)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana, Justina P, et al.
Publicado: (2018)

TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
por: Jin, Sheng Chih, et al.
Publicado: (2015)

Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience
por: Ridge, Perry G., et al.
Publicado: (2018)

Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease
por: Qiao, Min, et al.
Publicado: (2023)

Haplotype-based association analysis of the MAPT locus in Late Onset Alzheimer's disease
por: Mukherjee, Odity, et al.
Publicado: (2007)

Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
por: Ringman, John M., et al.
Publicado: (2014)

Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease
por: Chen, Hsiang-Han, et al.
Publicado: (2022)

Mitonuclear interactions influence Alzheimer’s disease risk
por: Andrews, Shea J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c7h0hfhr5grtg136dbfuq1u3r4